Announcements Trials
Browse Landscape

Status

Unknown 2

Sponsor Class

NIH 2

Study Type

Observational 2Interventional 2

Sponsor

Cancer Type

Other hematologic neoplasm 13Lymphoid 9Myeloid 6Plasma cell 3Other neoplasm 2Genitourinary 2Gastrointestinal 2CNS 2Breast 2Sarcoma 1Head & Neck 1

Conditions

Breast Neoplasms 2

Interventions

Surveys and Questionnaires 79Blood Specimen Collection 67palbociclib 40Trastuzumab 34Drug Therapy 30Letrozole 29Anastrozole 27Radiotherapy 26Immunohistochemistry 26Mastectomy, Segmental 22Amplified Fragment Length Polymorphism Analysis 22Fulvestrant 21Biopsy 21exemestane 20Tamoxifen 20Interviews as Topic 20Gene Expression Profiling 20Magnetic Resonance Spectroscopy 19ribociclib 18Specimen Handling 18Mastectomy 18Neoadjuvant Therapy 17Paclitaxel 16High-Energy Shock Waves 16Capecitabine 16trastuzumab deruxtecan 15Mammography 15Psychiatric Rehabilitation 14Polymerase Chain Reaction 13Observation 13

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Observational × Cytogenetic Analysis × Breast × Clear all
NCT01004796 2016-02-29

Study of Biomarkers in Tissue Samples From Patients With Breast Cancer

National Cancer Institute (NCI)

Unknown
Breast

Breast Neoplasms

NCT00898690 2013-12-18

Gene Expression in Predicting Response to Paclitaxel in Patients With Breast Cancer

National Cancer Institute (NCI)

Unknown
120 enrolled
Breast

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡